Arthur S. Przybyl
2013
In 2013, Arthur S. Przybyl earned a total compensation of $5.3M as President, Chief Executive Officer and Director at ANI Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $187,688 |
| Option Awards | $2,327,231 |
| Salary | $200,543 |
| Stock Awards | $2,399,115 |
| Other | $5,343 |
| Total | $5,319,920 |
Przybyl received $2.4M in stock awards, accounting for 45% of the total pay in 2013.
Przybyl also received $200K in bonus, $187.7K in non-equity incentive plan, $2.3M in option awards, $200.5K in salary and $5.3K in other compensation.
Rankings
In 2013, Arthur S. Przybyl's compensation ranked 1,169th out of 12,286 executives tracked by ExecPay. In other words, Przybyl earned more than 90.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,169 out of 12,286 | 91st |
Division Manufacturing | 382 out of 4,612 | 92nd |
Major group Chemicals And Allied Products | 102 out of 1,462 | 93rd |
Industry group Drugs | 65 out of 1,156 | 94th |
Industry Pharmaceutical Preparations | 57 out of 890 | 94th |
Source: SEC filing on April 14, 2016.
Przybyl's colleagues
We found six more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2013.
2013
Charlotte Arnold
ANI Pharmaceuticals
Chief Financial Officer
2013
Stephen Simes
ANI Pharmaceuticals
Chief Executive Officer
2013
James Marken
ANI Pharmaceuticals
Vice President, Operations
2013
Robert Schrepfer
ANI Pharmaceuticals
Vice President, New Business Development and Contract Manufacturing
2013
Phillip Donenberg
ANI Pharmaceuticals
Chief Financial Officer
2013
Robert Jamnick
ANI Pharmaceuticals